Effect of angiogenic and antiangiogenic compounds on the outgrowth of capillary structures from fetal mouse bone explants

Laboratory Investigation

Volumn 81, Issue 1, 2001, Pages 5-15

  Deckers, Martine ^a   Van Der Pluijm, Gabri ^a   Dooijewaard, Saskia ^a   Kroon, Marielle ^b   Van Hinsbergh, Victor ^b   Papapoulos, Socrates ^a   Löwik, Clemens ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; CD31 ANTIGEN; CHEMOKINE; COLLAGEN TYPE 1; ENDOSTATIN; FIBRIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PLASMIN INHIBITOR; RECOMBINANT VASCULOTROPIN; THALIDOMIDE DERIVATIVE; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BONE; CAPILLARY PROLIFERATION; CARTILAGE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; EXPLANT; FETUS; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; METATARSAL BONE; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0035139076     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780207     Document Type: Article

References (53)

1. Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature
2. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morpho-genesis, and sprouting angiogenesis
3. In vitro and in vivo systems to assess role of CXC chemokines in regulation of angiogenesis
4. Endogenous angiogenesis inhibitors: Angiostatin, endostatin, and other proteolytic fragments
5. Expression of vascular endothelial growth factors (VEGFs) and their receptors during osteoblast differentiation
6. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
7. Endostatin induces endothelial cell apoptosis
8. Opposite effects of osteogenic protein and transforming growth factor beta on chondrogenesis in cultured long bone rudiments
9. Vascularization of the mouse embryo: A study of flk-1, tek, tie, and vascular endothelial growth factor expression during development
10. Angiogenesis and metastasis
11. Toward a molecular understanding of skeletal development
12. The implications of angiogenesis for the biology and therapy of cancer metastasis
13. Interstitial collagenase is required for angiogenesis in vitro
14. Angiogenesis in cancer, vascular, rheumatoid and other disease
15. A corneal micropocket assay for angiogenesis in the rat eye
16. Factors involved in the modulation of cell proliferation in vivo and in vitro: The role of fibroblast and epidermal growth factors in the proliferative response of mammalian cells
17. Inhibition of terminal chondrocyte differentiation by bone morphogenetic protein 7 (OP-1) in vitro depends on the periarticular region but is independent of parathyroid hormone-related peptide
18. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
19. Extracellular matrix as a solid-state regulator in angiogenesis: Identification of new targets for anti-cancer therapy
20. Quantitative angiogenesis assays: Progress and problems
21. The chick embryo choriallantoic membrane as a bioassay for angiogenesis factors: Reactions induced by carrier materials
22. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells
23. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization
24. A model of angiogenesis in the mouse cornea
25. A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine
26. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix: Role of urokinase activity
27. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices
28. Endostatin inhibits microvessel formation in the ex vivo rat aortic rigenesis assay
29. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
30. Vascular out-growth from tissue explants embedded in fibrin or collagen gels: A simple in vitro model of angiogenesis
31. CXC chemokine modulation of angiogenesis: The importance of balance between angiogenic and angiostatic members of the family
32. The immuno-biology of interferon-gamma inducible protein 10 kD (IP-10): A novel, pleiotropic member of the C-X-C chemokine super-family
33. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro
34. Automatic vessel segmentation and quantification of the aortic ring assay of angiogenesis
35. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing
36. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
37. Manipulating angiogenesis
38. Proteolytic balance and capillary morphogenesis
39. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2
40. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector ex-pressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
41. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas
42. Angiostatin fragments in urine from patients with malignant disease
43. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis
44. Collagen as a sub-strate for cell growth and differentiation
45. The diagnostic and prognostic value of tumor angiogenesis
46. Inhibitory effect of full-length human endostatin on in vitro angiogenesis
47. Angiogenesis and its hormonal control in the corpeus luteum of the pregnant rat
48. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture
49. Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants
50. Matrix-degrading proteases and angiogenesis during development and tumor formation
51. Matrix metalloproteinase inhibitors
52. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
53. Migration of endothelial cells is stimulated by tumour-derived factors